School of Public Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
BMJ Open. 2023 Mar 3;13(3):e061370. doi: 10.1136/bmjopen-2022-061370.
Conduct a systematic review of existing frameworks to understand the for-profit private sector's roles in non-communicable disease (NCD) control and management. Control includes population-level control measures that prevent NCDs and mitigate the magnitude of the NCD pandemic, and management includes treatment and management of NCDs. The for-profit private sector was defined as any private entities that make profit from their activities (ie, pharmaceutical companies, unhealthy commodity industries, distinct from not-for-profit trusts or charitable organisations).
A systematic review and inductive thematic synthesis was performed. Comprehensive searches of PubMed, EMBASE, Cochrane Library, Web of Science, Business Source Premier and Proquest/ABI Inform were conducted on 15 January 2021. Grey literature searches were conducted on 2 February 2021 using the websites of 24 relevant organisations. Searches were filtered to only include articles published from the year 2000 onwards, in English. Articles that included frameworks, models or theories and the for-profit private sector's role in NCD control and management were included. Two reviewers performed the screening, data extraction and quality assessment. Quality was assessed using the tool developed by Hawker for qualitative studies.
The for-profit private sector.
There were 2148 articles initially identified. Following removal of duplicates, 1383 articles remained, and 174 articles underwent full-text screening. Thirty-one articles were included and used to develop a framework including six themes that outlined the roles that the for-profit private sector plays in NCD management and control. The themes that emerged included healthcare provision, innovation, knowledge educator, investment and financing, public-private partnerships, and governance and policy.
This study provides an updated insight on literature that explores the role of the private sector in controlling and monitoring NCDs. The findings suggest that the private sector could contribute, through various functions, to effectively manage and control NCDs globally.
对现有的框架进行系统回顾,以了解营利性私营部门在非传染性疾病(NCD)控制和管理中的作用。控制包括预防 NCD 并减轻 NCD 大流行程度的人群层面控制措施,管理包括 NCD 的治疗和管理。营利性私营部门被定义为从其活动中获利的任何私营实体(即制药公司、不健康商品行业,与非营利信托或慈善组织不同)。
进行了系统回顾和归纳主题综合分析。于 2021 年 1 月 15 日对 PubMed、EMBASE、Cochrane 图书馆、Web of Science、Business Source Premier 和 Proquest/ABI Inform 进行了全面检索。于 2021 年 2 月 2 日使用 24 个相关组织的网站对灰色文献进行了检索。搜索结果仅包括 2000 年以后发表的英文文章。纳入的文章包括框架、模型或理论以及营利性私营部门在 NCD 控制和管理中的作用。两名审查员进行了筛选、数据提取和质量评估。使用 Hawker 为定性研究开发的工具评估质量。
营利性私营部门。
最初确定了 2148 篇文章。去除重复项后,剩余 1383 篇文章,174 篇文章进行了全文筛选。纳入 31 篇文章,并用于制定一个框架,其中包括概述营利性私营部门在 NCD 管理和控制中所扮演角色的六个主题。出现的主题包括医疗保健提供、创新、知识教育者、投资和融资、公私合作伙伴关系以及治理和政策。
本研究提供了对探索私营部门在控制和监测 NCD 方面作用的文献的最新见解。研究结果表明,私营部门可以通过各种职能为全球有效管理和控制 NCD 做出贡献。